about
Antioxidant protection by haemopexin of haem-stimulated lipid peroxidationRole of hemoglobin/heme scavenger protein hemopexin in atherosclerosis and inflammatory diseasesIncorporation of haemoglobin haem into the rat hepatic haemoproteins tryptophan pyrrolase and cytochrome P-450Haem transport to the liver by haemopexin. Receptor-mediated uptake with recycling of the proteinIsolation of human haemopexin in apo-form by chromatography on S-Sepharose Fast Flow and Blue Sepharose CL-6B.BhuR, a virulence-associated outer membrane protein of Bordetella avium, is required for the acquisition of iron from heme and hemoproteins.Sites of formation of the serum proteins transferrin and hemopexin.Hemopexin induces neuroprotection in the rat subjected to focal cerebral ischemiaComparison of the abilities of different protein sources of iron to enhance Neisseria meningitidis infection in mice.Genetic studies of low-abundance human plasma proteins. VI. Polymorphism of hemopexin.Identification and purification of a hemoglobin-binding outer membrane protein from Neisseria gonorrhoeae.Genetic evidence that Neisseria gonorrhoeae produces specific receptors for transferrin and lactoferrinNrf2 to pre-condition the brain against injury caused by products of hemolysis after ICH.Evidence for in vivo expression of transferrin-binding proteins in Haemophilus influenzae type bEffects of serum carrier proteins on the growth of pathogenic neisseriae with heme-bound ironHaemophilus influenzae can use human transferrin as a sole source for required ironRepression by hematin of porphyrin biosynthesis in erythrocyte precursors in congenital erythropoietic porphyria.Heme on innate immunity and inflammation.Heme as a Target for Therapeutic Interventions.Serum glycoproteins and malignant neoplastic disorders.Iron and virulence in the family Enterobacteriaceae.Effect of iron compounds on antibacterial function of human polymorphs and plasma.Acute intermittent porphyria: pathophysiology and treatment.The use of wheat-germ lectin-Sepharose for the purification of human haemopexin.Heme cytotoxicity and the pathogenesis of immune-mediated inflammatory diseases.
P2860
Q24528194-8DCB7A36-2672-42C0-B7B5-937A00C34B45Q28266961-083652DA-8137-4C4C-ADA8-A43234971E42Q28362178-D68FB14A-87F8-4CF1-AA23-1BFECC55C3E6Q28678278-FF996215-C61F-4BE4-A582-1234EBBDD6C9Q33232421-278D560C-9C4D-49A7-921B-45901587A25AQ34132423-F01442A9-BC34-4E0E-851E-B7D824D68354Q34501360-21D5EE35-A969-4B6C-818F-4B644A12B4F9Q34768266-E6C73853-1AEB-416D-B249-9A9582C4AB28Q35100342-EC46BBAC-10FF-412C-A1D8-7489CB009D81Q35199508-FE5BF89B-3763-4A8C-BEB5-8BD4402BF12CQ35531161-BE08C4A9-FC07-4140-8AE1-B6778DDC4351Q36253781-84ED3BDC-81C2-4E7A-B0E0-F410FD00F595Q36573668-C42420B9-CF5E-4617-A8C9-F403BF2FE1D0Q36948147-BCB3A0BD-09F9-41A0-BADF-50411AB04F81Q37022650-C0F32E72-F017-419E-8AF3-37BE26EE3BE9Q37048551-4D0F41F3-665A-4879-AB59-CB3E016FF658Q37429497-9863C22B-62EB-463F-A822-5E2DFAC23575Q38218093-7CEAC70D-4D22-4194-8585-667B8A0065DEQ39249545-4B57CB45-15E6-4000-AA81-14DE18408ABFQ39461132-E964BDFB-726A-4981-A7CD-F90E3DB3A678Q39563860-4C9FD515-4361-4D04-8A3F-52DFB362C3D9Q40165454-77DA7292-8222-48B6-8069-ABF3A71AB8ABQ40180941-54439966-F6B7-4928-933B-099A64334A1BQ41364141-FF89BDAE-EC9A-483C-A288-F1AF7600A775Q41776151-BBF20E80-81F8-4240-B6A3-7869BCA5A994
P2860
description
1970 nî lūn-bûn
@nan
1970年の論文
@ja
1970年学术文章
@wuu
1970年学术文章
@zh-cn
1970年学术文章
@zh-hans
1970年学术文章
@zh-my
1970年学术文章
@zh-sg
1970年學術文章
@yue
1970年學術文章
@zh
1970年學術文章
@zh-hant
name
Hemopexin.
@en
Hemopexin.
@nl
type
label
Hemopexin.
@en
Hemopexin.
@nl
prefLabel
Hemopexin.
@en
Hemopexin.
@nl
P1476
Hemopexin.
@en
P2093
U Muller-Eberhard
P304
P356
10.1056/NEJM197011122832007
P407
P577
1970-11-01T00:00:00Z